| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| goserelin | leutinizing-hormone-releasing hormone | NA | Successful target | TTD , DGIDB | Disease Management[MeSHID:D019468] Carcinoma[MeSHID:D002277] Endometrium[MeSHID:D004717] Endometriosis[MeSHID:D004715] Malignant neoplasm of breast[MeSHID:D001943] Prostate[MeSHID:D011467] Metrorrhagia[MeSHID:D008796] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.83 | approved | unknown |
| goserelin | gonadotropin-releasing hormone receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Carcinoma[MeSHID:D002277] Endometrium[MeSHID:D004717] Endometriosis[MeSHID:D004715] Malignant neoplasm of breast[MeSHID:D001943] Prostate[MeSHID:D011467] Metrorrhagia[MeSHID:D008796] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.51 | approved | agonist |
| goserelin | lutropin-choriogonadotropic hormone receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Carcinoma[MeSHID:D002277] Endometrium[MeSHID:D004717] Endometriosis[MeSHID:D004715] Malignant neoplasm of breast[MeSHID:D001943] Prostate[MeSHID:D011467] Metrorrhagia[MeSHID:D008796] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
3.79 | approved | agonist |
| click here to return to the previous page | ||||||||